TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

TB-Speed Pneumonia
Conditions:   Tuberculosis;   Severe Pneumonia Intervention:   Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   UNITAID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

Community-based Tuberculosis Tracing and Preventive Therapy
Condition:   Tuberculosis Intervention:   Other: Screening and initiating preventive therapy in communities Sponsors:   Elizabeth Glaser Pediatric AIDS Foundation;   Epicentre;   University of Sheffield;   Institut de Recherche pour le Developpement Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
Condition:   Multi-drug Resistant Tuberculosis Intervention:   Drug: 18-month regimen containing 6 anti-TB drugs Sponsor:   Beijing Chest Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2019 Category: Research Source Type: clinical trials

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine for Treatment of Patients With MDR-TB
Condition:   Tuberculosis, Multidrug-Resistant Interventions:   Drug: Delamanid;   Drug: Levofloxacin;   Drug: Bedaquiline;   Drug: Clofazimine;   Drug: Linezolid;   Combination Product: WHO approved MDR-TB treatment regimens Sponsors:   Boston University;   United States Department of Defense;   Novartis Pharmaceuticals;   Pfizer;   Otsuka Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2019 Category: Research Source Type: clinical trials

Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis
Condition:   Multi-drug Resistant Tuberculosis Intervention:   Sponsors:   University of Cape Town;   Partners in Health;   Harvard Medical School;   Medicines Sans Frontieres Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2019 Category: Research Source Type: clinical trials